Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study

MLA

Jean-Michel Molina, et al. “Daily and On-Demand HIV Pre-Exposure Prophylaxis with Emtricitabine and Tenofovir Disoproxil (ANRS PREVENIR): A Prospective Observational Cohort Study.” The Lancet. HIV, vol. 9, no. 8, Dec. 2021. EBSCOhost, https://doi.org/10.1016/S2352-3018(22)00133-3⟩.

APA

Jean-Michel Molina, Jade Ghosn, Lambert Assoumou, Constance Delaugerre, Michèle Algarte-Genin, Gilles Pialoux, Christine Katlama, Laurence Slama, Geoffroy Liegeon, Lydie Beniguel, Michel Ohayon, Hanane Mouhim, Lauriane Goldwirt, Bruno Spire, Bénédicte Loze, Laure Surgers, Juliette Pavie, Jérémy Lourenco, Mohamed Ben-Mechlia, … Dominique Costagliola. (2021). Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study. The Lancet. HIV, 9(8). https://doi.org/10.1016/S2352-3018(22)00133-3⟩

Chicago

Jean-Michel Molina, Jade Ghosn, Lambert Assoumou, Constance Delaugerre, Michèle Algarte-Genin, Gilles Pialoux, Christine Katlama, et al. 2021. “Daily and On-Demand HIV Pre-Exposure Prophylaxis with Emtricitabine and Tenofovir Disoproxil (ANRS PREVENIR): A Prospective Observational Cohort Study.” The Lancet. HIV 9 (8). doi:10.1016/S2352-3018(22)00133-3⟩.